Paradigm Biocapital Advisors LP

Q2 2024 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2024
Date filed
8/14/2024
Form type
13F-HR
Num holdings
35
Total value ($000)
$2,613,016
Net value change ($000)
-227,736 (-8.0%)
New positions
10
Sold out positions
9
Turnover %
25.2%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2024 Next filing: 11/14/2024 SEC filing

Snapshot: Change Analysis

Compared to Q1 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Merus N.V. 119,512 NEW
RVMD 110,155 117.2%
JANX 65,535 NEW
NUVL 33,094 10.5%
COGT 30,553 NEW
BBIO 27,597 NEW
KURA 26,588 39.8%
ERAS 17,110 NEW
ARGX 14,040 6.5%
ASND 13,811 18.0%
Top Reduces (Value $000, Stocks/ETFs)
IMCR -116,166 -100.0%
ALPINE IMMUNE SCIENCES, INC. -84,083 -100.0%
BCYC -80,844 -100.0%
LEGN -57,876 -52.1%
ACLX -53,173 -20.0%
VRDN -50,418 -57.2%
ARVN -43,041 -39.9%
AUTL -40,997 -100.0%
TARS -37,890 -36.4%
PCVX -37,344 -44.1%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type